Literature DB >> 32496536

Severe Acute Respiratory Syndrome Coronavirus 2 Human Challenge Trials: Too Risky, Too Soon.

Liza Dawson1, Jake Earl1, Jeffrey Livezey2.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; coronavirus; ethics; human challenge studies; public trust; risk-taking; vaccines

Mesh：

Substances：

Year:  2020        PMID： 32496536      PMCID： PMC7313940          DOI： 10.1093/infdis/jiaa314

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  12 in total

1.  Research ethics and public trust in vaccines: the case of COVID-19 challenge trials.

Authors:  Nir Eyal
Journal:  J Med Ethics       Date:  2022-05-20       Impact factor: 5.926

2.  SARS-CoV-2 challenge studies: ethics and risk minimisation.

Authors:  Susan Bull; Euzebiusz Jamrozik; Ariella Binik; Michael J Parker
Journal:  J Med Ethics       Date:  2020-09-25       Impact factor: 2.903

3.  Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia.

Authors:  Søren Holm
Journal:  J Med Ethics       Date:  2020-07-02       Impact factor: 2.903

Review 4.  COVID-19 Vaccines: "Warp Speed" Needs Mind Melds, Not Warped Minds.

Authors:  John P Moore; P J Klasse
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

5.  Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate.

Authors:  Amin Addetia; Katharine H D Crawford; Adam Dingens; Haiying Zhu; Pavitra Roychoudhury; Meei-Li Huang; Keith R Jerome; Jesse D Bloom; Alexander L Greninger
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

Review 6.  Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposure.

Authors:  Nir Eyal; Marc Lipsitch
Journal:  Clin Microbiol Infect       Date:  2021-01-06       Impact factor: 8.067

Review 7.  Human challenge trials in vaccine development.

Authors:  Amrita Sekhar; Gagandeep Kang
Journal:  Semin Immunol       Date:  2020-11-29       Impact factor: 11.130

8.  Human Challenge Studies With Wild-Type Severe Acute Respiratory Sydrome Coronavirus 2 Violate Longstanding Codes of Human Subjects Research.

Authors:  Stanley M Spinola; Camilla Broderick; Gregory D Zimet; Mary A Ott
Journal:  Open Forum Infect Dis       Date:  2020-12-28       Impact factor: 3.835

9.  Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate.

Authors:  Amin Addetia; Katharine Hd Crawford; Adam Dingens; Haiying Zhu; Pavitra Roychoudhury; Meei-Li Huang; Keith R Jerome; Jesse D Bloom; Alexander L Greninger
Journal:  medRxiv       Date:  2020-08-14

10.  Public attitudes to a human challenge study with SARS-CoV-2: a mixed-methods study.

Authors:  Caroline Barker; Katharine Collet; Diane Gbesemete; Maria Piggin; Daniella Watson; Philippa Pristerà; Wendy Lawerence; Emma Smith; Michael Bahrami-Hessari; Halle Johnson; Katherine Baker; Ambar Qavi; Carmel McGrath; Christopher Chiu; Robert C Read; Helen Ward
Journal:  Wellcome Open Res       Date:  2022-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.